Cargando…
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review
INTRODUCTION: Individualizing glycemic targets to goals of care and time to benefit in persons with type 2 diabetes is good practice, particularly in populations at risk of hypoglycemia and adverse outcomes relating to the use of antihyperglycemics. Guidelines acknowledge the need for relaxed target...
Autores principales: | Black, Cody D., Thompson, Wade, Welch, Vivian, McCarthy, Lisa, Rojas-Fernandez, Carlos, Lochnan, Heather, Shamji, Salima, Upshur, Ross, Farrell, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306119/ https://www.ncbi.nlm.nih.gov/pubmed/27981503 http://dx.doi.org/10.1007/s13300-016-0220-9 |
Ejemplares similares
-
Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016) -
A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2023) -
Supporting deprescribing in long-term care: An approach using stakeholder engagement, behavioural science and implementation planning
por: McCarthy, Lisa M., et al.
Publicado: (2022) -
Community engagement in a disengaged world: Developing and
implementing educational workshops on deprescribing amid the COVID-19
pandemic
por: Conklin, James, et al.
Publicado: (2022) -
Developmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: protocol for a multiple case study
por: Conklin, James, et al.
Publicado: (2015)